James J. Burns & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
6,950
+3
+0% +$699 0.19% 55
2026
Q1
$1.7M Sell
6,947
-440
-6% -$102K 0.23% 54
2025
Q4
$1.53M Sell
7,387
-245
-3% -$48.4K 0.21% 57
2025
Q3
$1.42M Sell
7,632
-253
-3% -$43.3K 0.21% 56
2025
Q2
$1.2M Sell
7,885
-116
-1% -$17.8K 0.2% 57
2025
Q1
$1.33M Sell
8,001
-608
-7% -$95.1K 0.24% 55
2024
Q4
$1.25M Buy
8,609
+1,012
+13% +$157K 0.22% 57
2024
Q3
$1.23M Sell
7,597
-425
-5% -$67.7K 0.22% 57
2024
Q2
$1.17M Buy
8,022
+6,422
+401% +$955K 0.23% 56
2024
Q1
$252K Sell
1,600
-6,481
-80% -$1.03M 0.09% 75
2023
Q4
$1.27M Buy
8,081
+72
+0.9% +$11K 0.3% 46
2023
Q3
$1.25M Sell
8,009
-294
-4% -$48.5K 0.34% 45
2023
Q2
$1.37M Buy
8,303
+215
+3% +$34.7K 0.35% 46
2023
Q1
$1.25M Buy
8,088
+6,701
+483% +$1.08M 0.32% 51
2022
Q4
$245K Buy
1,387
+1
+0.1% +$173 0.1% 71
2022
Q3
$226K Buy
+1,386
New +$235K 0.1% 73

Other funds holding JNJ

James J. Burns & Company's JNJ Position: Q2 2026 in Review

James J. Burns & Company increased its Johnson & Johnson (JNJ) stake by 0.04% in Q2 2026, buying an estimated $699 and bringing the position to 6,950 shares worth $1.77M. The position accounts for 0.19% of the portfolio, ranked #55.

James J. Burns & Company first reported a position in JNJ in Q3 2022 and has held it in 16 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • James J. Burns & Company held 6,950 shares of Johnson & Johnson worth $1.77M as of Q2 2026.
  • James J. Burns & Company bought 3 Johnson & Johnson shares in Q2 2026, an estimated $699.
  • Johnson & Johnson made up 0.19% of James J. Burns & Company's portfolio in Q2 2026, its #55 holding.
  • James J. Burns & Company first reported a position in Johnson & Johnson in Q3 2022 and has held it in 16 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on James J. Burns & Company's 13F filing for Q2 2026, filed 6 Aug 2026.